Clinical Research Directory

Inclusion Criteria: 1. Patients diagnosed with Helicobacter pylori positivity through 13C-UBT or 14C-UBT 2. Patients who have not received eradication treatment for Helicobacter pylori in the past, or who have failed eradication in the early stage but have not received eradication treatment within six months 3. Voluntarily participate in this experiment and sign an informed consent form Exclusion Criteria: 1. Allergies to research drugs (such as those allergic to penicillin, amoxicillin, keverprazan) 2. Patients with peptic ulcer 3. Patients who have received Helicobacter pylori eradication treatment within six months 4. Use antibiotics or bismuth medication 4 weeks before starting the study；use P-CAB or PPI 2 weeks before starting the study 5. Using corticosteroids, non steroidal anti-inflammatory drugs, or anticoagulants 6. Those who are using atazanavir, nelfinavir, rilpivirine, itraconazole, tyrosine kinase inhibitors (imatinib, gefitinib, etc.), digoxin, and methyl digoxin 7. History of esophageal or gastric surgery 8. Pregnant or lactating women 9. Suffering from serious concomitant diseases such as liver disease, cardiovascular disease, lung disease, or kidney disease 10. Excessive drinking 11. Gastric mucosa-associated lymphoid tissue lymphoma (MALT), malignant neoplastic diseases